Ocumension Therapeutics's total assets for Q2 2025 were ¥3.90B, a decrease of -1.93% from the previous quarter. HK:1477 total liabilities were ¥243.82M for the fiscal quarter, a 21.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.